Menu

Association between interleukin-18 variants and prostate cancer in Slovak population

J. JURECEKOVA, E. BABUSIKOVA, M. KMETOVA SIVONOVA, H. DROBKOVA, M. PETRAS, J. KLIMENT, E. HALASOVA

Abstract:

Interleukin-18 (IL-18), pro-inflammatory cytokine, plays important role in antitumor immunity. Polymorphisms in the IL-18 gene may lead to its altered production/activity and such modulate susceptibility to prostate cancer. The aim of this study was to evaluate the relationship between the -607 and +105 polymorphisms in the IL-18 gene and the risk of prostate cancer development and progression in Slovak population. The study was performed using 425 patients with prostate cancer, 270 patients with benign prostatic hyperplasia (BHP) and 263 healthy male controls. The statistically significant association of the -607 AC genotype (OR = 2.24; p No association of the IL-18 -607 polymorphism and BHP was detected. The subset analysis revealed the significant association of the -607 AC genotype (OR = 2.01; p = 0.008) with development of higher-grade carcinomas (Gleason score ≥7) and the strong association of the -607 AC genotype (OR = 3.11; p

Issue: 1/2017

Volume: 2017

Pages: 148 — 155

DOI: 10.4149/neo_2017_119

Pubmed

Shopping cart is empty